AGT – Advances in Gene and Cell Therapy [transcript] [audio]
Guest: Jeff Galvin
Presenter: Neal Howard
Guest Bio: Jeff Galvin is CEO of American Gene Technologies International Inc. (AGT), a gene technology company with a broad and robust lentiviral delivery platform.
Segment overview: Mr. Jeff Galvin discusses his vision for the future of healthcare led by advances in gene and cell therapy that parallel the rapid and transformative advances seen in the information technology sector.
Transcript – TBU
0 Comments